SCINAI IMMUNOTHERAPEUTICS LT (SCNI)
US09073Q3039 - ADR
ChartMill assigns a Buy % Consensus number of 83% to SCNI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 714. This target is 20647.37% above the current price.
SCNI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SCNI.
In the previous month the buy percentage consensus was at a similar level.
SCNI was analyzed by 7 analysts. More opinions would make the average more meaningful.